<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="4183">
  <stage>Registered</stage>
  <submitdate>12/11/2013</submitdate>
  <approvaldate>12/11/2013</approvaldate>
  <nctid>NCT02000063</nctid>
  <trial_identification>
    <studytitle>Australian Trial in Acute Hepatitis C Recall Study</studytitle>
    <scientifictitle>Long-term Outcomes Following Treatment of Recently Acquired Hepatitis C Virus Infection.</scientifictitle>
    <utrn />
    <trialacronym>ATAHC Recall</trialacronym>
    <secondaryid>VHCRP1105</secondaryid>
    <secondaryid>VHCRP1105</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Acute Hepatitis C</healthcondition>
    <conditioncode>
      <conditioncode1>Infection</conditioncode1>
      <conditioncode2>Other infectious diseases</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions />
    <comparator />
    <control />
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Long-term effects of HCV clearance - Health related quality of life (measured by SF-12) Social functioning (measured by OTI survey) Injecting behaviour Mental health (measured by DASS and MINI) Liver health (measured by FibroScan and biochemical markers)</outcome>
      <timepoint>4 to 8 years from initial infection</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Incidence of HCV re-infection - Rate of HCV RNA positivity in patients previously HCV RNA negative.</outcome>
      <timepoint>4 to 8 years from initial infection</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Previous enrolment in the Australian Trial of Acute Hepatitis C Virus Infection
             (ATAHC) Study.

          -  Provision of written, informed consent.</inclusivecriteria>
    <inclusiveminage>16</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  In the opinion of the investigator that the patient is not able to provide informed
             consent.

          -  Inability or unwillingness to comply with study collection requirements.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/08/2012</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>50</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/03/2014</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW,SA,VIC</recruitmentstate>
    <hospital>St Vincent's Hospital - Sydney</hospital>
    <hospital>Royal Adelaide Hospital - Adelaide</hospital>
    <hospital>The Alfred Hospital - Melbourne</hospital>
    <postcode>2010 - Sydney</postcode>
    <postcode>5000 - Adelaide</postcode>
    <postcode>3005 - Melbourne</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Kirby Institute</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>The University of New South Wales</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>A single long-term follow up assessment of an established multi-centre, prospective
      longitudinal cohort study of patients for clinical, psychosocial, immunovirological outcomes
      4 to 8 years after previous treatment for recently acquired hepatitis C virus infection.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT02000063</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Gail Matthews, MBChB, MRCP (UK), FRACP, PhD</name>
      <address>University of New South Wales, Syndey Australia</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>